Screener
Opko Health OPK SG&A
SG&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| Line item | For the three months ended June 30, 2026 | For the three months ended June 30, 2025 | For the six months ended June 30, 2026 | For the six months ended June 30, 2025 |
|---|---|---|---|---|
| Costs and expenses: | ||||
| Cost of service revenue | 58,462 | 82,383 | 114,604 | 166,901 |
| Cost of product revenue | 25,101 | 25,022 | 47,399 | 47,836 |
| Selling, general and administrative | 52,924 | 59,597 | 101,531 | 118,683 |
| Research and development | 33,166 | 30,342 | 62,365 | 61,183 |
| Amortization of intangible assets | 18,969 | 19,444 | 37,935 | 39,304 |
| Gain on sale of assets | (18,070) | — | (18,070) | — |
| Total costs and expenses | 170,552 | 216,788 | 345,764 | 433,907 |
Item 1. Financial Statements
FAQ
- What is Opko Health's SG&A?
- Opko Health (OPK) reported SG&A of $52.92M in Q2 2026.
- How has Opko Health's SG&A changed year-over-year?
- Opko Health's SG&A decreased by 11.2% year-over-year, from $59.6M to $52.92M.
- What is the long-term trend for Opko Health's SG&A?
- Over 3 years (2021 to 2025), Opko Health's SG&A has grown at a -21.9% compound annual growth rate (CAGR), from $468.86M to $223M.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.
Ask your AI about Opko Health's sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude